Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
215.77
-5.12 (-2.32%)
Aug 11, 2026, 4:00 PM EDT - Market closed
Axsome Therapeutics Market Cap
Axsome Therapeutics has a market cap or net worth of $11.3 billion as of August 12, 2026. Its market cap has increased by 116.12% in one year.
Market Cap
11.30B
Enterprise Value
11.21B
1-Year Change
116.12%
Ranking
Category
Stock Price
$215.77
ChartMarket Cap Chart
Since November 19, 2015, Axsome Therapeutics's market cap has increased from $154.90M to $11.30B, an increase of 7,196.46%. That is a compound annual growth rate of 49.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 11.30B | 22.75% |
| Dec 31, 2025 | 9.21B | 124.55% |
| Dec 31, 2024 | 4.10B | 8.87% |
| Dec 29, 2023 | 3.77B | 12.44% |
| Dec 30, 2022 | 3.35B | 135.22% |
| Dec 31, 2021 | 1.42B | -53.19% |
| Dec 31, 2020 | 3.04B | -14.70% |
| Dec 31, 2019 | 3.57B | 4,141.14% |
| Dec 31, 2018 | 84.10M | -36.58% |
| Dec 29, 2017 | 132.60M | 2.55% |
| Dec 30, 2016 | 129.30M | -21.30% |
| Dec 31, 2015 | 164.30M | 6.07% |
| Nov 19, 2015 | 154.90M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Exelixis | 12.97B |
| Arrowhead Pharmaceuticals | 12.70B |
| Madrigal Pharmaceuticals | 12.23B |
| Corcept Therapeutics | 12.19B |
| Summit Therapeutics | 12.14B |
| Halozyme Therapeutics | 11.70B |
| Bio-Techne | 11.23B |
| ABIVAX Société Anonyme | 11.06B |